Life Care Center Of Leominster | |
370 West Street, Leominster, Massachusetts 01453 | |
(978) 537-0771 | |
Name | Life Care Center Of Leominster |
---|---|
Location | 370 West Street, Leominster, Massachusetts |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 133 |
Occupancy Rate | 68.05% |
Medicare ID (CCN) | 225038 |
Legal Business Name | Fairlawn Medical Investors, Llc |
Ownership Type | For Profit - Corporation |
NPI Number | 1669435616 |
Organization Name | FAIRLAWN MEDICAL INVESTORS, LLC |
Doing Business As | LIFE CARE CENTER OF LEOMINSTER |
Address | 370 West St, Leominster, MA 01453 |
Phone Number | 978-343-4411 |
News Archive
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Bromfenac Ophthalmic Solution, 0.09%, based on a development and supply agreement with Coastal Pharmaceuticals.
OncoGenex Pharmaceuticals, Inc. announced today data from a Phase 2 study of its investigational compound OGX-427 in chemotherapy-naive metastatic castration resistant prostate cancer (mCRPC) patients will be presented during an oral presentation at the 2012 American Society of Clinical Oncology (ASCO) annual meeting on Tuesday, June 5.
The Cuban state-owned company Labiofam "is increasing sales of its mosquito larvicides to fight malaria in Africa, despite cautions by U.N. experts that such products have limited use and are not the most cost-effective method of attacking the disease," the Miami Herald reports.
Michael Dell today shared his insights with healthcare executives on how information technology is being used to improve the efficiency and quality of care today and how IT can support future innovations in prevention, wellness and personalized medicine.
› Verified 4 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Bromfenac Ophthalmic Solution, 0.09%, based on a development and supply agreement with Coastal Pharmaceuticals.
OncoGenex Pharmaceuticals, Inc. announced today data from a Phase 2 study of its investigational compound OGX-427 in chemotherapy-naive metastatic castration resistant prostate cancer (mCRPC) patients will be presented during an oral presentation at the 2012 American Society of Clinical Oncology (ASCO) annual meeting on Tuesday, June 5.
The Cuban state-owned company Labiofam "is increasing sales of its mosquito larvicides to fight malaria in Africa, despite cautions by U.N. experts that such products have limited use and are not the most cost-effective method of attacking the disease," the Miami Herald reports.
Michael Dell today shared his insights with healthcare executives on how information technology is being used to improve the efficiency and quality of care today and how IT can support future innovations in prevention, wellness and personalized medicine.
› Verified 4 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 21.51 | 14.46 |
Percentage of long-stay residents who lose too much weight | 13.73 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 54.41 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.96 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 3.41 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 0.72 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 2.33 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 87 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 10.6 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 52.28 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 1.66 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 34.28 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 18.9 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 7.05 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.01 | 95.98 |
Percentage of short-stay residents who made improvements in function | 66.02 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 77.51 | 82.93 |
News Archive
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Bromfenac Ophthalmic Solution, 0.09%, based on a development and supply agreement with Coastal Pharmaceuticals.
OncoGenex Pharmaceuticals, Inc. announced today data from a Phase 2 study of its investigational compound OGX-427 in chemotherapy-naive metastatic castration resistant prostate cancer (mCRPC) patients will be presented during an oral presentation at the 2012 American Society of Clinical Oncology (ASCO) annual meeting on Tuesday, June 5.
The Cuban state-owned company Labiofam "is increasing sales of its mosquito larvicides to fight malaria in Africa, despite cautions by U.N. experts that such products have limited use and are not the most cost-effective method of attacking the disease," the Miami Herald reports.
Michael Dell today shared his insights with healthcare executives on how information technology is being used to improve the efficiency and quality of care today and how IT can support future innovations in prevention, wellness and personalized medicine.
› Verified 4 days ago
Life Care Center Of Leominster Location: 370 West Street, Leominster, Massachusetts 01453 Phone: (978) 537-0771 | |